Pharming Group to participate in February investor conferences
08 Febbraio 2024 - 8:00AM
Leiden, The Netherlands, February 8,
2024: Pharming Group N.V. (“Pharming”) (Euronext
Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management
will participate in the following investor conferences in the month
of February:
- Oppenheimer
34th Annual Healthcare Life
Sciences Virtual Conference, February 13-14, 2024Sijmen de
Vries, Chief Executive Officer, will present on Tuesday, February
13 at 11:20 ET/17:20 CET. A live webcast and replay of the
presentation will be available in the “Upcoming Events” and “News”
sections of Pharming’s website.
- UBS
European Healthcare Conference, London, U.K., February 28,
2024
For more information about these conferences, or
to schedule a one-to-one meeting with Pharming’s management team,
please contact Pharming’s Investor Relations team at
investor@pharming.com or your Oppenheimer or UBS
representative.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam:
PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated
to transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules, biologics, and
gene therapies that are in early to late-stage development.
Pharming is headquartered in Leiden, Netherlands, and has employees
around the globe who serve patients in over 30 markets in North
America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
For further public information,
contact:
Pharming Group, Leiden, The
NetherlandsMichael Levitan, VP Investor Relations &
Corporate CommunicationsT: +1 (908) 705 1696
Heather Robertson, Investor Relations &
Corporate Communications ManagerE: investor@pharming.com
FTI Consulting, London, UKVictoria
Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000
LifeSpring Life Sciences Communication,
Amsterdam, The NetherlandsLeon MelensT: +31 6 53 81 64
27E: pharming@lifespring.nl
Grafico Azioni Pharming Group NV (EU:PHARM)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Pharming Group NV (EU:PHARM)
Storico
Da Gen 2024 a Gen 2025
